Skip to main content
. 2017 Aug 2;8(40):68599–68613. doi: 10.18632/oncotarget.19803

Figure 3. Colour map representation of gefitinib-induced tyrosine phophorylation inhibition in peptide profiles obtained with the combined 37 patients described in Figures 1 and 2.

Figure 3

Patient samples are sorted in columns according to their survival status. Rows represent the peptides sorted according to their correlation with survival status. As depicted in the colour bar scale, a red colour indicates a relatively high “inhScor” value, a Log2-transformed ratio of tyrosine phosphorylation inhibition by gefitinib. The significance obtained in the t test per peptide is indicated on the left side of the figure using the following coding: OOO, p < 0.001; OO, p < 0.01; O, p < 0.05; p ≥ 0.05 otherwise.